Business Description
Innovative Pharmaceutical Biotech Ltd
ISIN : BMG4783W1073
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -0.44 | |||||
Debt-to-Equity | -1.66 | |||||
Debt-to-EBITDA | 3.2 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.87 | |||||
Beneish M-Score | -3.52 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -15.7 | |||||
3-Year EBITDA Growth Rate | 36.6 | |||||
3-Year EPS without NRI Growth Rate | -15.2 | |||||
3-Year FCF Growth Rate | 21.7 | |||||
3-Year Book Growth Rate | -26.7 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.44 | |||||
9-Day RSI | 36.92 | |||||
14-Day RSI | 39.55 | |||||
6-1 Month Momentum % | -7.11 | |||||
12-1 Month Momentum % | -5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.02 | |||||
Quick Ratio | 0.02 | |||||
Days Sales Outstanding | 333.54 | |||||
Days Payable | 275.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -28.15 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 10.66 | |||||
Operating Margin % | -250.61 | |||||
Net Margin % | 830.52 | |||||
FCF Margin % | -250 | |||||
ROE % | Neg. Equity | |||||
ROA % | 4.59 | |||||
ROIC % | -0.91 | |||||
ROC (Joel Greenblatt) % | 30998.47 | |||||
ROCE % | 51.6 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 38.6 | |||||
EV-to-EBIT | 4.27 | |||||
EV-to-EBITDA | 4.27 | |||||
EV-to-Revenue | 173.22 | |||||
EV-to-FCF | -69.29 | |||||
Earnings Yield (Greenblatt) % | 23.42 | |||||
FCF Yield % | -5.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Innovative Pharmaceutical Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 7.664 | ||
EPS (TTM) (HK$) | -0.113 | ||
Beta | 0.26 | ||
Volatility % | 37.49 | ||
14-Day RSI | 39.55 | ||
14-Day ATR (HK$) | 0.008132 | ||
20-Day SMA (HK$) | 0.1997 | ||
12-1 Month Momentum % | -5 | ||
52-Week Range (HK$) | 0.185 - 0.37 | ||
Shares Outstanding (Mil) | 1,723.19 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Innovative Pharmaceutical Biotech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Innovative Pharmaceutical Biotech Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Innovative Pharmaceutical Biotech Ltd Frequently Asked Questions
What is Innovative Pharmaceutical Biotech Ltd(HKSE:00399)'s stock price today?
When is next earnings date of Innovative Pharmaceutical Biotech Ltd(HKSE:00399)?
Does Innovative Pharmaceutical Biotech Ltd(HKSE:00399) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |